Research: Cholesterol-Lowering Links with Oat Beta-Glucan

20 Oct 2014 --- A new meta-analysis published in the American Journal of Clinical Nutrition shows that daily consumption of at least 3g oat beta-glucan reduces cholesterol levels. This effect was observed in lean, overweight and obese male and female adults, with and without type 2 diabetes, across 28 randomized controlled trials. A link to the paper can be found here.

Lowering cholesterol to reduce cardiovascular risk is an accepted lifestyle modification recommended by European and US guidelines. Health claims regarding the association between cholesterol lowering and soluble fiber from at least 3g per day oat beta-glucan have been approved by food agencies worldwide, including EFSA and FDA. 

The cholesterol-lowering effect of oat beta-glucan depends on its viscosity in the small intestine, and therefore its molecular weight. A high molecular weight means it can be released from the food matrix during digestion and form a viscous gel inside the small intestine. 

Author Dr Thomas Wolever explains: “We now know more about the importance of the physico-chemical properties of oat beta-glucan in determining its ability to reduce cholesterol and blood glucose in humans. Our meta-analysis is the first to take this information into account by only including studies using high molecular weight oat beta-glucan.”

Numerous clinical studies with DSM’s OatWell oat beta-glucan also confirm this positive effect, as well as the EFSA positive opinion. The proven efficacy of OatWell formed the basis of the Article 14 EFSA submission . 

A recent paper published in the British Journal of Nutrition  looks more closely at the functional properties of oat beta-glucan. The authors review a number of studies using OatWell that demonstrate high viscosity oat beta-glucan can reduce cholesterol and the rise of blood sugar levels after eating. This included oat beta-glucan in food matrices such as oat bran and oat bran cereals .

To consume the recommended 3g per day of oat beta-glucan, only 11g of OatWell is required to achieve the same effect as three portions (up to 90g) of oats. 

EFSA Scientific Opinion on the substantiation of a health claim related to oat beta-glucan and lowering blood cholesterol and reduced risk of (coronary) heart disease pursuant to Article 14 of Regulation (EC) No 1924/2006 can be found here. 

Related Articles

Business News

BASF: “considerable” Q2 earnings growth, but Nutrition & Health sales stall

27 Jul 2017 --- BASF Group has announced that its second quarter sales rose by 12 percent to €16.3 billion (US$19.11 billion) compared with the same period in 2016. The group states that this was largely attributable to higher prices and volumes. Amid higher raw material costs, the company raised sales prices by 7 percent; this was mainly driven by higher prices in the Chemicals segment. Sales volumes increased by 3 percent. Currency effects had a positive impact on sales and, like portfolio effects, accounted for a 1 percent increase.

Regulatory News

Cargill’s erythritol dental health claim rejected by EFSA

27 Jul 2017 --- Cargill cannot prove its EU Article 14 claim submission [disease risk reduction claim] that there is a cause-and-effect relationship between sugar-free hard confectionery with at least 90 percent erythritol and the reduction of dental plaque, according to the European Food Safety Authority (EFSA).

Business News

Algatech eyes Brazil market following Anvisa approval for astaxanthin line

27 Jul 2017 --- Algatechnologies has received Brazilian Health Regulatory Agency (Anvisa) approval for its all-natural astaxanthin AstaPure to be used as a food ingredient. This approval makes Algatech the first astaxanthin supplier to start marketing its clean-label astaxanthin under the AstaPure brand in Brazil. 

Nutrition & Health News

Binge drinking among young US adults not in college increased

27 July 2017 --- Binge drinking rates are finally down among US college students aged 18 to 24, after years of increases, but they are up among those in the same age group who are not in college, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs. The same study also found that alcohol-related hospitalizations and overdose deaths have increased generally among 18- to 24-year-olds.

Business News

Food and health startups get chance to impress in Innovation Challenge

27 Jul 2017 --- Innovative ingredient projects, carried out by startups that have brought something completely new and unexpected to the food and health markets, will be rewarded as part of the Startup Innovation Challenge during the next Fi Europe & Ni show from November 28 to 30 this year.

More Articles
URL : http://www.nutritioninsight.com:80/news/Research-Cholesterol-Lowering-Links-with-Oat-Beta-Glucan.html